Caption Management, LLC Halozyme Therapeutics, Inc. Put Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	BUY	$39.51 - $51.45 $1.41 Million - $1.84 Million	35,800 New	35,800 $1.49 Million
Q2 2020 Aug 14, 2020	SELL	$16.25 - $26.81 $975,000 - $1.61 Million	-60,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $1.46 Million - $2.29 Million	-105,000 Reduced 63.64%	60,000 $1.08 Million
Q4 2019 Feb 13, 2020	BUY	$14.93 - $19.53 $1.12 Million - $1.46 Million	75,000 Added 83.33%	165,000 $2.93 Million
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $1.37 Million - $1.59 Million	90,000 New	90,000 $1.4 Million
Q4 2018 Jan 30, 2019	SELL	$13.33 - $18.66 $333,250 - $466,500	-25,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$16.68 - $18.41 $8.29 Million - $9.15 Million	-497,200 Reduced 95.21%	25,000 $454,000
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $8.75 Million - $10.9 Million	522,200	522,200 $10.6 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.